Thryv Therapeutics Advances THRV-1268 in Long QT S...
Category : ODD/BTA/FTA Status 27 April 2026Fast Track status + Phase 2/3 dosing marks a critical inflection point. A small biotech just made a...
Odd Bta Fta Status
Eris Lifesciences Disrupts the GLP-1 Market with ₹...
Category : ODD/BTA/FTA Status 23 March 2026The semaglutide price war in India just hit a new low. Eris Lifesciences Limited has launched its ge...
US FDA grants Breakthrough Therapy designation to...
Category : ODD/BTA/FTA Status 20 March 2026Sanofi announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy des...
FDA Grants Breakthrough Therapy Designation to Sut...
Category : ODD/BTA/FTA Status 8 March 2026Hemab Therapeutics has received a major regulatory boost after the U.S. Food and Drug Administration...
Veloxis’ VEL-101 Granted FDA Orphan Drug Designati...
Category : ODD/BTA/FTA Status 22 January 2026Veloxis Pharmaceuticals, Inc., a global specialty pharmaceutical company and part of Asahi Kasei Cor...
Latest Newsletter Post
-
Mabwell Receives FDA IND Clearance..
9 May 2026
-
Bayer Reports Positive Phase III Re..
9 May 2026
-
Cardiol Therapeutics Reports Positi..
8 May 2026
-
Alebund Pharmaceuticals Completes E..
8 May 2026
-
Tremfya Shows Breakthrough Results..
8 May 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com